GD2 expression in breast cancer. - Wikidata - wikimedia - TriplyDB

GD2 expression in breast cancer.

GD2 expression in breast cancer.

http://www.wikidata.org/entity/Q33761830

about

Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects.

P2860

Q47135344-BC9A4F33-2519-40E0-A4BE-5813BB1CA108

P2860

GD2 expression in breast cancer.

http://www.wikidata.org/entity/Q33761830

description

2017 nî lūn-bûn

@nan

2017 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մարտին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

GD2 expression in breast cancer.

@ast

GD2 expression in breast cancer.

@en

type

label

GD2 expression in breast cancer.

@ast

GD2 expression in breast cancer.

@en

prefLabel

GD2 expression in breast cancer.

@ast

GD2 expression in breast cancer.

@en

P1433

Q33761830-521BAC6F-1229-4E21-AF9C-CFDBD6A3BA92

P1476

Q33761830-7B7C0C59-ABF4-4489-89EE-E68277503FBC

P2093

Q33761830-131324C2-87A1-48ED-8924-BB4D3765743A

Q33761830-385FACB2-5B24-4C41-B188-21F452BEE2DA

Q33761830-5A04FA97-5C73-43BC-B599-981C5F87EF6C

Q33761830-93FBBC04-A3B2-46E9-B124-4573963781CE

Q33761830-9EE00C23-23D2-40A4-8E84-7C3A10F5E873

Q33761830-C079C2CB-5D6E-40D3-AEEF-D55EA582E6A3

Q33761830-DACA1F7B-6D87-40FF-8E64-36063C6B2705

Q33761830-DDE48EC5-3F37-4546-BCE3-3CDAEB9EBF4A

Q33761830-FB4E34CD-BE86-4A3D-8787-0BFE97A4535A

Q33761830-FC501765-8C1B-4080-98FA-84B227AC2BCA

P2860

Q33761830-05F8A18D-D5F8-448F-95CB-A000D4EAE4DB

Q33761830-0BD61E69-2C75-42F4-B3DF-768A9E3507CC

Q33761830-0EDB0642-824A-477C-ADC1-5A169A7510EE

Q33761830-10CA1D35-861E-4288-B36D-AF2FB7E25F84

Q33761830-111F20F8-1DFF-4E39-9651-C3F8CDE9B692

Q33761830-13BD88BF-28CD-4301-81DC-42712C4C86C8

Q33761830-1402A9C9-B493-496E-A6E2-9CC743AAEB30

Q33761830-2457338C-9B30-4C9D-8BE5-10D73CC6CADE

Q33761830-24CCFC8C-AD16-41BB-8268-FC9079115090

Q33761830-35C4BF38-F3BE-49F7-8894-062FCB6400B8

P304

Q33761830-C629CD3E-1084-404F-B0E8-1870AD774B4E

P31

Q33761830-3C701AFE-5157-45B7-ADFC-84E8AE2053D2

P356

Q33761830-E1FBD4E0-9FF5-45CE-AC3B-84E37284BDAA

P407

Q33761830-6731F3B6-AFF6-41A6-896D-87A85AD98335

P433

Q33761830-ECB19D30-AB25-4221-B284-1C5F381006DA

P478

Q33761830-B1081FB4-224E-4086-B0CE-4BA3A233879B

P50

Q33761830-114A45F2-7E34-4F16-A3C8-C08581A22290

Q33761830-1BE98AF8-764A-42FE-BC3E-44FC79DF8A81

Q33761830-79DB9BBC-B7F4-4BF2-B7DF-533F09AB0C19

Q33761830-81D73F06-DB7F-40CC-B251-9B7CC7DCE783

Q33761830-832F5B7C-D2F4-423E-8154-2D5E68E2B32D

Q33761830-E5484C65-B722-4381-8794-33CA626D8E31

Q33761830-EF2ADF3D-C589-4321-88D3-1E13156D6F9D

Q33761830-F40C8381-9521-4E29-B700-333BAA67DD31

P577

Q33761830-60330FFE-6E30-4CA8-9CC7-12ACF11ECA73

P698

Q33761830-6892D8AE-7F69-4C97-A60F-CDA56405FF7B

P932

Q33761830-0973A1D2-1837-4166-AEC3-4AE26C741104

P356

ONCOTARGET.16363

P1433

P1476

GD2 expression in breast cancer

@en

P2093

Carlotta Spano

http://www.w3.org/2001/XMLSchema#string

Enrico Orvieto

http://www.w3.org/2001/XMLSchema#string

Federico Piacentini

http://www.w3.org/2001/XMLSchema#string

Giovanni Tazzioli

http://www.w3.org/2001/XMLSchema#string

Guido Ficarra

http://www.w3.org/2001/XMLSchema#string

Ilenia Mastrolia

http://www.w3.org/2001/XMLSchema#string

Monica Barbolini

http://www.w3.org/2001/XMLSchema#string

Paola Manni

http://www.w3.org/2001/XMLSchema#string

Roberto D'Amico

http://www.w3.org/2001/XMLSchema#string

Tiziana Petrachi

http://www.w3.org/2001/XMLSchema#string

P2860

Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells

Molecular portraits of human breast tumours

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells.

Deconstructing the molecular portraits of breast cancer.

Breast cancer prognostic classification in the molecular era: the role of histological grade.

Gangliosides with O-acetylated sialic acids in tumors of neuroectodermal origin.

P304

31592-31600

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.16363

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Stefano Cascinu

PierFranco Conte

Massimo Dominici

Maria Vittoria Dieci

Valentina Guarneri

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28415563

http://www.w3.org/2001/XMLSchema#string

P932

5458232

http://www.w3.org/2001/XMLSchema#string